Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The... see more

NDAQ:TLRY - Post Discussion

Tilray Brands, Inc. > The more Shorts the more haters on TLRY
View:
Post by CaneIsAbel on Feb 04, 2024 9:50am

The more Shorts the more haters on TLRY

Tilray brands the more we're getting it right. Only great companies and people have haters that dedicate time to come bash anything to Rob your TLRY shares your dreams that are sharesby millions like you who buy and trade in Tilray Brands every day.  The same millions of people that are going to force the shorts to buy back 125 million shares and send them into oblivion where they belong. Take a look at upcoming catlysts. 

1: Germany vote on recreational largely expected to pass  Tilray Brands has a GMP certified domestic facility in Germany with 20 percent medical market share already in the country with Tilray Pharma formerly CC Pharma  
2. Canadian changing regulations  the government of Canada is reviewing its marijuana policies and is widely expected to reduce excise taxes and allow advertising by the legal market.  Many companies have shuttered leaving Tilray Brands to consume more market share on a growing multi billion dollar Canadian domestic cannabis industry  
3: rescheduling in the USA will signal the changing laws where Tilray Brands will be enabled to import medical cannabis  we already reside in much of the USA with adjacent buisness that has grown by 110 percent in a very short few quarters  
4: Our booze and hemp business in the USA continues to grow dominate markets across the states  we also win multiple awards  
5: Millions in synergies yet to be realized and revenue by our recently bought beverage USA companies and our Truss buy now fully being integrated  
6: We are still on track to cash free flow positivity  Tilray Brabds generates enough money to run it's business.  Irwin Simon recently stated in an interview much of the burn is non operating costs such as acquisitions and one time law suits settled related too hexo.  We don't give a dam about Hexo, Tilray Brands just wanted their assets and market share and we now have it  
7: Our excess capacities related to our Hexo buy netted us a massive facility that at this time will be repurposed towards vegetable growing.  That will enable Tilray Brands to generate millions on domestic demand in Quebec currently importing vegetables.  If we sold the facility as is, it would have netted us Pennie's on the dollar unacceptable to Tilray Brands smart managment  reurposed we could profit now and later reconvert or sell it for millions.  

much more as well but gotta run  cheers good luck to all

Comment by slottygoddy on Feb 04, 2024 12:10pm
But yet no run-up in the stock price.  In other words, its already priced in..  Not trying to be mean, the selling pressure will continue as smart money shifts from LP's to MSOS's.  The next run in LPs will be in late 2026 when MSOS's have access to debt and equity markets to raise funds to make purchases.  At best, TLRY will get to $2.50 - $3.00 this year.  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities